In his well-publicized directive on stem cells, President Bush was clear: Federal funds may finance scientific research only on certain stem-cell lines in existence on or before Aug. 9, 2001. Less clear, however, is the issue of whether the financing of a facility with tax-exempt bonds restricts the type of stem-cell research performed at the facility. The issue is particularly pressing in California, where voters have made up to $10 billion available to support human embryonic stem-cell research. In a recent BNA article, John Chesley and Glenn Krinsky, health care partners at Ropes & Gray, analyze the issue and conclude that using tax-exempt bonds to finance a facility does not restrict ensuing stem-cell research. Click "Download PDF" above to read their article.
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.